Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Dermatologists diagnose and manage melanoma more effectively than general practitioners.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Naproxen is not the cause of hair loss in a child; it's due to a toxic event with expected hair regrowth.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Pregnancy can cause symptoms similar to rheumatic diseases, making diagnosis difficult, and affects various body systems, requiring careful distinction between normal changes and serious conditions.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Elastic Net DNA methylation clocks are inaccurate for predicting age and health status; a "noise barometer" may better indicate aging and disease.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

TNF-alpha inhibitors can cause various immune-related skin issues.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

Biologics for severe asthma have known side effects, but some new risks need more study.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

New cytokine-targeted therapies show promise for treating alopecia areata.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.